Literature DB >> 30148674

Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.

Chien-Ming Lin1,2, Chih-Jen Cheng3, Sung-Sen Yang1,3, Min-Hua Tseng1,4, Ming-Tso Yen1,5, Chih-Chien Sung1,3, Shih-Hua Lin1,3.   

Abstract

The Kelch-like 3 ( KLHL3) mutations contributed to the most common causative genes in patients with pseudohypoaldosteronism type II (PHAII); however, the molecular mechanisms of PHAII-causing mutations in BTB domain of KLHL3 in vivo have not been investigated. We generated and analyzed Klhl3 knock-in (KI) mice carrying a missense M131V mutation in the BTB domain (corresponding to human KLHL3 M78V mutation). Klhl3M131V/+ KI mice exhibited typical PHAII phenotype with an exaggerated diuretic response to hydrochlorothiazide. Their kidney tissues showed an unchanged KLHL3, decreased cullin 3 (Cul3), and increased with-no-lysine kinases (WNKs) WNK1 and WNK4 along with an enhanced downstream ste20-related proline/alanine-rich kinase/oxidative stress response kinase 1-N(K)CC phosphorylation. Their Cul3 protein in the cytosol of distal convoluted tubule cells was also significantly attenuated on immunogold-labeling electron microscopy. In microdissected renal tubules, Klhl3M131V/+ KI mice expressed high levels of Wnk4 mRNA in the distal nephron. In vitro coimmunoprecipitation showed the KLHL3 BTB domain mutation retained intact interaction with WNKs but reduced binding to Cul3, thus leading to the increased abundance of total WNKs. In summary, Klhl3M131V/+ KI mice feature typical PHAII with a simultaneous increase of WNK1 and WNK4 through the impaired KLHL3 BTB domain binding to Cul3.-Lin, C.-M., Cheng, C.-J., Yang, S.-S., Tseng, M.-H., Yen, M.-T., Sung, C.-C., Lin, S.-H. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.

Entities:  

Keywords:  Cullin 3; Kelch-like 3; PHAII; with-no-lysine kinases

Mesh:

Substances:

Year:  2018        PMID: 30148674     DOI: 10.1096/fj.201801023R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

Review 1.  Kelch-like protein 3 in human disease and therapy.

Authors:  Yan Lin; Qian Li; Xiaofeng Jin
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

Review 2.  WNK1 in Malignant Behaviors: A Potential Target for Cancer?

Authors:  Ji-Ung Jung; Ankita B Jaykumar; Melanie H Cobb
Journal:  Front Cell Dev Biol       Date:  2022-06-22

3.  UBR5 is a novel regulator of WNK1 stability.

Authors:  Ji-Ung Jung; Anwesha B Ghosh; Svetlana Earnest; Staci L Deaton; Melanie H Cobb
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-20       Impact factor: 5.282

Review 4.  WNK4 kinase: from structure to physiology.

Authors:  Adrián Rafael Murillo-de-Ozores; Alejandro Rodríguez-Gama; Héctor Carbajal-Contreras; Gerardo Gamba; María Castañeda-Bueno
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-25

5.  KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.

Authors:  Man Yang; Ya-Mei Han; Qiang Han; Xue-Zhu Rong; Xiao-Fang Liu; Xu-Yong Ln
Journal:  J Cell Mol Med       Date:  2021-08-28       Impact factor: 5.310

Review 6.  The Molecular Genetics of Gordon Syndrome.

Authors:  Holly Mabillard; John A Sayer
Journal:  Genes (Basel)       Date:  2019-11-29       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.